Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancerH J Burstein, I Kuter, S M Campos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2019
The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trialR Barroso-Sousa, W T Barry, H Guo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2018
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 studyS Adams, P Schmid, H S Rugo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2018
Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 studyS Adams, S Loi, D Toppmeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2020
TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarkerE L Mayer, V Abramson, R Jankowitz, et al.
The Pharmacogenomics Journal|February 12, 2014
Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance)A Chhibber, J Mefford, E A Stahl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2018
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancerG N Hortobagyi, S M Stemmer, H A Burris, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Breast CancerR W Carlson, B O Anderson, W Bensinger, et al.
Breast Cancer Research and Treatment|November 21, 2016
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)Rachel A Freedman, D K Seisler, J C Foster, et al.
ESMO Open|January 18, 2025
HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancersF Lynce, O Martínez-Sáez, B Walbaum, et al.
Pageof 9